Meek, Claire L. http://orcid.org/0000-0002-4176-8329
Funding for this research was provided by:
National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre
Diabetes UK (17/0005712)
Novo Nordisk Foundation Center for Basic Metabolic Research (NNF19SA058974)
BMA Foundation for Medical Research (Helen H Lawson Award)
Article History
Received: 10 March 2023
Accepted: 12 June 2023
First Online: 13 July 2023
Acknowledgements
: The author wishes to thank Dr Laura Kusinski and Dr Clive Petry (University of Cambridge) for proof-reading and constructive feedback on the final manuscript. This was an invited review after a presentation of the same name delivered at the EASD conference in 2022.
: CLM receives funding from Diabetes UK (17/0005712), the BMA Foundation (Helen H Lawson Award), the European Foundation for the Study of Diabetes–Novo Nordisk Foundation (NNF19SA058974) and the National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre (BRC). The views expressed are those of the author and not necessarily those of the NIHR or the Department of Health and Social Care.
: The author declares that there are no relationships or activities that might bias, or be perceived to bias, their work.
: The author was the sole contributor to this manuscript.